Self-screening of Cognitive Impairment in Primary Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-27

Study Completion Date

2020-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

According to 2011 HAS recommendations, early detection of Alzheimer disease is the major objective in order to allow an earlier care and support. These recommendations strengthen general practitioner role, who plays a key role in the identification of cognitively impaired patients. HAS recommendations are the use of MMSE like test (Mini Mental State Examination) at general practitioner office. A self-screening test, without medical presence, would allow a self-administered cognitive assessment by the patient. A review of the literature about self-administered cognitive tests has been realized. The Self-Administered Gerocognitive Examination (SAGE) has been chosen. It is a brief, valid and reliable cognitive assessment tool, rated on 22 points, which allows an early detection of cognitive impairment, with a sensitivity close to the MMSE test. Nevertheless, SAGE has never been tested at home without medical supervision. In this study, the investigators will determine if SAGE scores at home correlates with MMSE scores at general practitioner office.

Patients with inclusion criteria will be recruited during the general practitioner consultation and will have a clinical assessment included MMSE and clinical data collection. Then, SAGE will be given to the patient in order to be completed at home without medical supervision and send to the general practitioner.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SAGE for the Early Detection of Cognitive Impairment at Primary Care Provider Visits

NCT04063371

Cognitive Impairment

COMPLETED

Integrating eSAGE With EHR Data Using Machine Learning for the Early Detection and Monitoring of Cognitive Impairment in Individuals

NCT06017505

Dementia Alzheimer Disease Mild Cognitive Impairment +1 more

ENROLLING_BY_INVITATION

Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)

NCT02544074

Mild Cognitive Impairment Dementia

COMPLETED

Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders

NCT01316562

Alzheimer's Disease Impaired Cognition Memory Disorders

UNKNOWN

Home-based Cognitive Monitoring in MCI

NCT04350801

Mild Cognitive Impairment

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognition Disorder Alzheimer Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SAGE and MMSE score

Group Type OTHER

MMSE (mini mental state examination)

Intervention Type OTHER

mini mental state examination takes place during the consultation. The consultation is a general or post-emergency geriatric consultation.

SAGE (Self-Administered Gerocognitive Exam)

Intervention Type OTHER

SAGE test contains a series of questions that assess the cognitive functioning. Sage was developed by the Ohio State University Wexner Medical Center. it's an online, at-home, self-screening dementia tool that has been scientifically evaluated, and it's demonstrated good results in accurately identifying cognitive deficits.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MMSE (mini mental state examination)

mini mental state examination takes place during the consultation. The consultation is a general or post-emergency geriatric consultation.

Intervention Type OTHER

SAGE (Self-Administered Gerocognitive Exam)

SAGE test contains a series of questions that assess the cognitive functioning. Sage was developed by the Ohio State University Wexner Medical Center. it's an online, at-home, self-screening dementia tool that has been scientifically evaluated, and it's demonstrated good results in accurately identifying cognitive deficits.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects from three Picard general practitioner's practice
* 60 years old or more
* patients who accept to complete the tests
* with ou without cognitive complaint
* patients able to read and write
* affiliated to social security system